P&G Ventures is looking for solutions to help men age with vitality and live their fullest lives.
The 2024 MIT Health Science Technology Conference will highlight broad and transformative trends in biology and healthcare, including early-stage discovery, immune cell responses, diagnostics, clinical capabilities, process development, rapid and continuous manufacturing, robotics and automation, and sustainability, all enhanced by artificial intelligence and machine learning technologies. Leading MIT researchers and MIT-connected startups will showcase these advances and discuss their implications for improving human health.
How can P&G enable consumers to do radically more with radically less water and energy use? How can we make invisible use of water & energy visible, right at the point of use? How might we particularly address the triangle of tension that exists between improving sanitization, reducing water & energy, whilst keeping the feeling of abundance of using water?. From incremental evolution to product innovation, easy-retrofit water-infrastructure changes (taps, faucets, showerheads, etc.) and water appliances that aim at both reducing (hot) water and re-using/purifying/enriching (hot) water, we want to partner!
Hear from distinguished MIT faculty and startups on topics such as recent advances in precision medicine for a more targeted and personalized treatment, immunotherapy to fight cancer cells, gene therapy, AI to improve diagnosis, treatment, and patient outcomes, and more.
PathAI is evolving pathology using machine learning and deep learning techniques to drive faster more accurate diagnosis of disease.
P&G is looking for new approaches and technologies that can help them to address key business challenges/opportunities.
James J. Collins, Termeer Professor of Medical Engineering & Science, MIT & co-founder of Enbiotix, Synlogic, and multiple other startups fostered in the Collins lab, including Sample6.
Trond Undheim, PhD, Program Director, MIT Startup Exchange; Paula Hammond, PhD, David H. Koch Professor in Engineering and Department Head, Chemical Engineering, MIT; Laura Indolfi, PhD, CEO of PanTher Therapeutics; Peter Sandor, VP, Head of Oncology Marketing Strategy, Astellas.
Synthetic Biology Workshop 2017 - Panel Discussion